Translational highlights in breast cancer research and treatment: recent developments with clinical impact
Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019/02/01
|
| In: |
Current opinion in obstetrics and gynecology
Year: 2019, Volume: 31, Issue: 1, Pages: 67-75 |
| ISSN: | 1473-656X |
| DOI: | 10.1097/GCO.0000000000000510 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1097/GCO.0000000000000510 |
| Author Notes: | Peter A. Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, Johannes Ettl, Tanja Fehm, Friedrich Overkamp, and Diana Lüftner |
| Summary: | Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm |
|---|---|
| Item Description: | Gesehen am 10.07.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1473-656X |
| DOI: | 10.1097/GCO.0000000000000510 |